Introducing HYPERSCAN , Pencil Beam Scanning Delivery HYPERSCAN enables tumor volumes to be scanned in a matter of seconds, benefiting from the MEVION S250's direct and efficient beam generation. The result is a fast Pencil Beam Scanning enabling robust Intensity Modulated Proton Therapy treatment delivery that is much less sensitive to patient and tumor motions, ultimately increasing the efficacy of the treatment procedure. The MEVION S250 proton therapy platform with HYPERSCAN allows you to treat with precision, accuracy and reproducibility at unparalleled speed with uncompromised beam quality. Designed for greater access by any size cancer care facility, the MEVION S250 significantly reduces the complexity, size, and cost associated with conventional proton therapy systems. The MEVION S250 is specifically engineered as upgrade-ready to continue providing the most advanced proton therapy treatment available today as well as tomorrow. Key Features : Field-Upgradeable; Streamlined Clinical Workflow with Full OIS Integration; High-Accuracy Beam Pointing with Submillimeter Position Tracking; Fast Volumetric and Layer Rescanning Capabilities; Supports Standard Gating Interface for Beam On/Off Hold
VIDEO: Preserving Neurocognitive Function During Whole-Brain Radiotherapy
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., co-director of the Brain Tumor Center at the Northwestern Medicine Cancer Center, about the long-term results of a radiation therapy technique called hippocampal avoidance to preserve neurocognitive function for cancer patients with brain metastases at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting.
Watch the VIDEO: Advancements in Radiation Therapy for Brain Cancer and the VIDEO: Multidisciplinary Treatment of Brain Tumors, a previous two-part interview with Gondi.
Kettering's oncolcogy services worked with Elekta to provide the latest radiation therapy with the Veras HD system.
AAPM President John E. Bayouth, Ph.D., discusses the impact of imaging in medical physics, as well as training that is available through AAPM, with Imaging Technology News Editorial Director Melinda Taschetta-Millane.
Peter G. Maxim, Ph.D., assistant professor of radiation oncology at Stanford University, discusses stereotactic radiotherapy for renal sympathetic nerve ablation for the treatment of refractory hypertension, and some of the challenges involved, with Imaging Technology News Editorial Director Melinda Taschetta-Millane.
Paul Keall, Ph.D., FAAP, professor and NHMRC Australian Fellow at Radiation Physics Laboratory at the University of Sydney, Sydney Medical School, discusses radiosurgery beyond cancer. He explains how radiotherapy might be used to ablate cardiac tissue noninvasively, which could eliminate the need for the current invasive, catheter-based ablation therapies used in electrophysiology.
Kettering Medical Center Therapist, Sarah Macke, describes how their center improved their treatment process with safety and efficiency.
Varian Medical Systems celebrates its 65-year anniversary, focused around innovation, partnership, collaboration and service. As it looks to the next 65 years, the company's vision is focused on a world without fear of cancer. Varian's goal is to work closely with the clinical community to help remove fear, provide better tools and also software solutions that will improve care over time. At ASTRO 2013, Varian highlighted what is new this year: The first installations of the Edge Radiosurgery Suite CT on Rails solution for brachytherapy, in partnership with Siemens' Aria and Eclipse Version 11, with over 500 installations to date; Connectivity to Siemens accelerators currently in the process of regulatory filing; Launch of RapidPlan Knowledge-based planning system
Varian Medical Systems launched RapidPlan Knowledge-based Planning at ASTRO 2013. RapidPlan is a new paradigm for treatment planning that will change the way planning is done by helping facilities capture actual clinical practices based on treatment plans that have been done in the past. RapidPlan will help busy clinics increase efficiency overall for the treatment planning process. For clinics new to the technology, models from other clinics can be used, applying past learning experiences to their own model. And with academic medical centers, RapidPlan is a great tool for narrowing the variations between the different clinicians within the practice itself.
Esteya electronic brachytherapy by Nucletron, an Elekta company, is a new, high-precision treatment solution for treating skin cancer. Esteya mimics high dose rate (HDR) brachytherapy by bringing a miniaturized X-ray source very close to the cancerous site, enabling the local application of radiation for effective treatment. By virtue of this direct delivery, Esteya can concentrate more therapeutic radiation to the disease target and minimize radiation to the surrounding tissues and organs. Notably, Esteya requires only minimal room shielding and features a compact design and exceptional mobility, allowing the treatment to occur virtually anywhere patients are seen. Esteya represents a desirable alternative to surgery, the therapy that patients most commonly select to treat their skin cancer. Esteya features: Patient-friendly design, with a high dose rate that enables treatment delivery in less than three minutes; user-centric operation, offering a highly efficient workflow and easy patient set-up; and attractive economic profile
AAPM President John Hazle, Ph.D., discusses trends in medical physics and major initiatives that the association is addressing in 2014 with Imaging Technology News Editorial Director Melinda Taschetta-Millane.
Varian introduced the Edge radiosurgery Suite during ASTRO 2012. The system features real-time tumor tracking and a six-degree of freedom couch.
At ASTRO 2012, IBA featured a scale model install of its Proteus One compact proton system combined with the Philips Ambient Experience, designed to count patients through lighting visual effects.
At ASTRO 2012, Mevion featured its compact Mevion S250 Proton Therapy System, which has a footprint comparable to traditional radiation therapy systems.
At ASTRO 2012, Ray Search Americas demonstrated the latest features for its radiation therapy treatment planning system.
Dr. Gary Ezzell, president of the American Association of Physicists in Medicine (AAPM), talks about current trends in medical physics, particularly the melding of imaging and radiation therapy to guide treatment. He also recaps some of the hot topics discussed at this year's annual meeting in Charlotte, N.C., and AAPM's key initiatives for the coming year.
IBA Dosimetry offers commissioning services for linear accelerators (linacs), using state-of-the-art equipment like the Blue Phantom and the linear diode array. A variety of service options are available, from a turnkey operation to segmented individual services or post-installation support, depending on the customer's needs. Utilizing these services can help a clinic get up-and-running in the quickest time possible. Customers also can utilize IBA's new International Competence Center (ICC) to receive training to do commissioning on their own. For more information, visit www.iba-dosimetry.com
Gary Levine, M.D., program chair/incoming president of the National Consortium of Breast Centers, discusses the emergence of interoperative radiation therapy (IORT) at the 22nd annual National Interdisciplinary Breast Center Conference (NCoBC), held in Las Vegas in March.
IBA ProteusONE offers uncompromised treatment solutions enabling physicians to leverage the clinical effectiveness of proton beam therapy. While Pencil Beam Scanning enables the delivery of Intensity Modulated Proton Therapy (IMPT) treatment plans, the latest imaging techniques make Image Guided Proton Therapy (IGPT) possible. ProteusONE has been inspired by everyday clinical practice. Its design enhances the patient experience by fostering a soothing environment while making the medical staff's daily practice safer and easier. Finally ProteusONE is IBA's response to making protons affordable. It is a proton therapy system that is smaller, more affordable, easier to install, easier to operate and ultimately easier to finance. With ProteusONE, protons are possible for more patients worldwide.
For more information: www.iba-worldwide.com
At ASTRO 2010, one of the big topics was how radiation oncology as a profession is in a period of retrenchment due to the economic crisis. There is also a growing demand from payors to show value for these treatments, said American Society for Radiation Oncology (ASTRO) President Anthony Zeitman, M.D., director, Harvard Radiation Oncology Residency Program, Jenot and William Shipley Professor of Radiation Oncology at Harvard Medical School. He said the radiotherapy technologies used need to undergo rigorous clinical testing to show what technologies and techniques work best and what is most cost-effective. Part of ASTRO's push is for a national registry to help advance this data collection.